Bupropion Hydrochloride Tablet, Film Coated, Extended Release
Product Images NDC 82868-097

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Bupropion Hydrochloride (NDC 82868-097). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (82868 097 96 Rev A 12 25 Nhc)

Label (82868 097 96   Rev A 12 25 Nhc)
Label for Bupropion Hydrochloride Extended-Release Tablets, USP (XL) 150 mg, containing 180 film-coated tablets. The label indicates prescription use only and provides storage instructions and warnings not to use in combination with a monoamine oxidase inhibitor. Labeler is Northwind Health Company, LLC.*
FDA Label Image

Bupropion Hydrochloride Chemical Structure (Bupropion Hydrochloride Sr 1)

Bupropion Hydrochloride Chemical Structure (Bupropion Hydrochloride Sr 1)
Chemical structure of bupropion hydrochloride showing the arrangement of atoms including a chlorophenyl group and hydrochloride salt.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.